Table 8.
Region | Number of studies | Subjects | SMD | [95% CI] | Overall effect | Heterogeneity | |||
---|---|---|---|---|---|---|---|---|---|
PD | AD | Z | P | I 2 [%] | P | ||||
Global | 2 | 20 | 29 | −3.27 | [−6.86, 0.32] | −1.785 | 0.074 | 85.6 | 0.008 |
Frontal lobe | 3 | 26 | 39 | −2.21 | [−4.11, −0.31] | −2.274 | 0.023 | 83.9 | 0.002 |
Parietal lobe | 2 | 20 | 29 | −2.75 | [−6.15, 0.65] | −1.585 | 0.113 | 86.7 | 0.006 |
Occipital lobe | 2 | 20 | 29 | −1.70 | [−2.62, −0.78] | −3.625 | 0 | 26.0 | 0.245 |
Temporal lobe | 2 | 20 | 29 | −2.75 | [−5.75, 0.24] | −1.804 | 0.071 | 83.8 | 0.013 |
PD, Parkinson's disease; AD, Alzheimer's disease; SMD, Standardized mean difference; CI, confidence interval. The bold values indicate the value of P < 0.05.